1 study found for:    C14008
Show Display Options
Rank Status Study
1 Active, not recruiting MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer
Conditions: Ovarian Carcinoma;   Fallopian Tube Cancer;   Peritoneal Cancer;   Breast Carcinoma
Interventions: Drug: MLN8237 + Paclitaxel;   Drug: MLN8237+Paclitaxel vs. Paclitaxel alone

Indicates status has not been verified in more than two years